TRexBio is a biotech company using computational biology tools and expertise in immunobiology to develop innovative treatments for cancer and inflammatory diseases. Their 'deep biology' discovery engine maps human tissue Treg behavior to identify new targets for therapy. They are creating a diverse range of therapies that restore immune homeostasis in human tissue.